- News>
- States
Bangalore Bio 2003 begins
Bangalore, Apr 15: More than 120 companies from 20 countries are participating in `Bangalore Bio 2003,`, the third annual international biotech tradeshow.
Bangalore, Apr 15: More than 120 companies from 20
countries are participating in "Bangalore Bio 2003,", the third annual international biotech tradeshow.
The three-day tradeshow is organised by Karnataka government and sponsored by United Kingdom. Denmark and France have given their endorsement to the show and would send business delegations.
Twelve Indian premier research labs would also participate in the event to showcase institutional R&D. Bangalore bio, projected as Asia`s premier biotech event, would see the launch of "Bangalore Helix," the much-awaited biotech park in the city, and "able," the association of biotech led enterprises.
"Bangalore Helix, which has received inquiries from major Bt companies, will be unveiled tomorrow," Karnataka it and Bt minister D B Inamdar told reporters here. Chairperson of Karnataka`s vision group on biotechnology Kiran Mazumdar Shaw said able would be the Nasscom equivalent for the biotechology industry. "What Nasscom is for it, able will be for the biotech sector to create awareness about the industry," she said.
Over 70 speakers including scientists and technologists would attend the conference that would dwell on bioprocessing, platform technologies, bioinformatics and venture capital funding among others. A "Double Helix" sculpture by noted Artist Yusuf Arakkal would be unveiled on M G Road here to commemorate 50 years of DNA discovery, it was stated.
A business-to-business meet is being organised at the event to help biotech companies identify business partners, for which 18 meetings have been confirmed, officials said.
Shaw said biotechnology offered for India enormous growth opportunities in the health and agri-biotech sector.
"Biotechnology is new for India. The growth is enormous. It cannot be compared to the IT industry which largely depends on the US. Here the national needs comes first and potential is enormous and there are regulatory hurdles to go overseas," she said.
There would be public sessions on "An Indian DNA Vaccine for Rabies"; "stem cells for therapy-problems and prospects"; "structural genomics of disease causing microbes- an Indian effort"; "vaccines and vaccinology: the past, present and future"; and "Bt growth in India-A reality check".
Bureau Report
Twelve Indian premier research labs would also participate in the event to showcase institutional R&D. Bangalore bio, projected as Asia`s premier biotech event, would see the launch of "Bangalore Helix," the much-awaited biotech park in the city, and "able," the association of biotech led enterprises.
"Bangalore Helix, which has received inquiries from major Bt companies, will be unveiled tomorrow," Karnataka it and Bt minister D B Inamdar told reporters here. Chairperson of Karnataka`s vision group on biotechnology Kiran Mazumdar Shaw said able would be the Nasscom equivalent for the biotechology industry. "What Nasscom is for it, able will be for the biotech sector to create awareness about the industry," she said.
Over 70 speakers including scientists and technologists would attend the conference that would dwell on bioprocessing, platform technologies, bioinformatics and venture capital funding among others. A "Double Helix" sculpture by noted Artist Yusuf Arakkal would be unveiled on M G Road here to commemorate 50 years of DNA discovery, it was stated.
A business-to-business meet is being organised at the event to help biotech companies identify business partners, for which 18 meetings have been confirmed, officials said.
Shaw said biotechnology offered for India enormous growth opportunities in the health and agri-biotech sector.
"Biotechnology is new for India. The growth is enormous. It cannot be compared to the IT industry which largely depends on the US. Here the national needs comes first and potential is enormous and there are regulatory hurdles to go overseas," she said.
There would be public sessions on "An Indian DNA Vaccine for Rabies"; "stem cells for therapy-problems and prospects"; "structural genomics of disease causing microbes- an Indian effort"; "vaccines and vaccinology: the past, present and future"; and "Bt growth in India-A reality check".
Bureau Report